Market Overview

20 Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

  • New Concept Energy, Inc. (NYSE: GBR) rose 105.3 percent to $3.01 in pre-market trading after Realty Advisors disclosed a new 2.81 percent stake in the company.
  • PEDEVCO Corp. (NYSE: PED) shares rose 45.5 percent to $3.76 in pre-market trading after climbing 659.62 percent on Wednesday.
  • Renmin Tianli Group, Inc. (NASDAQ: ABAC) rose 16.7 percent to $3.22 in pre-market trading after gaining 15.55 percent on Wednesday.
  • Marvell Technology Group Ltd. (NASDAQ: MRVL) shares rose 13.3 percent to $22.80 in pre-market trading after the company reported receipt of Chinese regulatory approval for Cavium acquisition.
  • Zosano Pharma Corporation (NASDAQ: ZSAN) rose 11.1 percent to $4.22 in pre-market trading. On Wednesday, Zosano Pharma issued a mid-day press release highlighting added analysis from ZOTRIP study will be present at AHS meeting. BTIG Research initiated coverage on Zosano Pharma with a Buy rating and a $19 price target.
  • The Madison Square Garden Company (NYSE: MSG) rose 9 percent to $290.25 in pre-market trading after the company disclosed that its board has unanimously approved plans to explore possible spinoff. The company plans to separate sports businesses from live entertainment units to create 2 publicly-traded companies.
  • Cronos Group Inc (NASDAQ: CRON) rose 8.4 percent to $6.70 in pre-market trading after declining 8.98 percent on Wednesday.
  • Emerge Energy Services LP (NYSE: EMES) shares rose 6.6 percent to $7.75 in pre-market trading.
  • Cavium Inc (NASDAQ: CAVM) rose 5.7 percent to $84 in pre-market trading. Marvell Technology reported receipt of Chinese regulatory approval for Cavium acquisition.
  • R.R. Donnelley & Sons Company (NYSE: RRD) rose 5.7 percent to $6.36 in pre-market trading after dropping 5.94 percent on Wednesday.
  • GNC Holdings Inc (NYSE: GNC) shares rose 5.3 percent to $3.80 in pre-market trading after declining 5.00 percent on Wednesday.
  • Puxin Limited (NYSE: NEW) shares rose 5.2 percent to $21.90 in pre-market trading after declining 7.96 percent on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Pier 1 Imports, Inc. (NYSE: PIR) shares fell 15 percent to $2.55 in pre-market trading after the company reported weak sales for its first quarter. Comps were down 8.2 percent in the quarter. The company sees comps down 6-7 percent in the second quarter.
  • Differential Brands Group Inc. (NASDAQ: DFBG) fell 11.9 percent to $4.80 in pre-market trading. Differential Brands Group shares jumped over 500 percent Wednesday following deal to buy majority of North American unit of Global Brands Group for $1.38 billion.
  • Zafgen, Inc. (NASDAQ: ZFGN) fell 7.1 percent to $7.90 in pre-market trading after announcing pricing of offering of common stock.
  • Summit Therapeutics plc (NASDAQ: SMMT) fell 5.9 percent to $2.40 in the pre-market trading session after dropping 79.84 percent on Wednesday.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 5.6 percent to $19.05 in pre-market trading. Bed Bath & Beyond reported in-line earnings for its first quarter. Comps were down 0.6 percent in the quarter.
  • Pain Therapeutics, Inc. (NASDAQ: PTIE) shares fell 5.5 percent to $2.30 in pre-market trading after declining 71.45 percent on Wednesday.
  • Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) fell 4.2 percent to $20.00 in pre-market trading. Innovate Biopharmaceuticals announced plans to collaborate with a professor at the University of Maryland.
  • AeroVironment, Inc. (NASDAQ: AVAV) fell 3.9 percent to $64.068 in pre-market trading after climbing 7.07 percent on Wednesday.

Posted-In: Losers Premarket MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas

 

Related Articles (AVAV + ABAC)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut

Nike Q4 Earnings Preview